All News

Diabetic Ketoacidosis Raises Risk of In-Hospital Mortality, Hospital Readmission in Heart Failure

May 17, 2022

Diabetic ketoacidosis increased the likelihood of in-hospital mortality by 61%, the likelihood of major adverse cardiovascular events by 56%, and a likelihood of 30-day readmission by 12% among patients hospitalized with heart failure in the US.

New Research Underlines the Importance of Early Interventions in Type 2 Diabetes

May 16, 2022

A University of Surrey-led study found patients achieving optimal glucose control in the first 12 months proceeding a T2D diagnosis had a lower risk of cardiovascular events than their counterparts who did not achieve optimal glucose control.

Tirzepatide (Mounjaro) Wins FDA Approval for Type 2 Diabetes

May 13, 2022

Announced on May 13, the approval indicates Eli Lilly and Company's novel dual GLP-1/GIP agonist, tirzepatide (Mounjaro), for use as an adjunct to diet and exercise to improve blood sugar in adult patients with type 2 diabetes.

Thyroid Dysfunction Could Increase Risk of Parkinson Disease

May 13, 2022

A systematic review and meta-analysis from AACE 2022 provides an overview of the potential associations between thyroid dysfunction, including both hypothyroidism and hyperthyroidism, and risk of Parkinson disease.

Most Endocrinology Fellowship Programs Lack Formal Nutrition Education, Study Finds

May 13, 2022

Results of a survey and literature review presented at AACE 2022 detail the lack of formal nutrition education available in endocrinology fellowship programs as well as the desire to see a greater emphasis placed on nutrition education in these programs.